Invasive aspergillosis has been mainly reported among immunocompromised patients during prolonged periods of neutropenia. Recently, however, non-neutropenic patients in the ICU population have shown an increasing risk profile for aspergillosis. Associations with chronic obstructive pulmonary disease and corticosteroid therapy have been frequently documented in this cohort. Difficulties in achieving a timely diagnosis of aspergillosis in non-neutropenic patients is related to the non-specificity of symptoms and to lower yields with microbiological tests compared to neutropenic patients. Since high mortality rates are typical of invasive aspergillosis in critically ill patients, a high level of suspicion and prompt initiation of adequate antifungal treatment are mandatory. Epidemiology, risk factors, diagnostic algorithms, and different approaches in antifungal therapy for invasive aspergillosis in non-neutropenic patients are reviewed.

Bassetti, M., Righi, E., De Pascale, G., De Gaudio, R., Giarratano, A., Mazzei, T., Morace, G., Petrosillo, N., Stefani, S., Antonelli, M., How to manage aspergillosis in non-neutropenic intensive care unit patients, <<CRITICAL CARE>>, 2014; 18 (4): 458-458. [doi:10.1186/s13054-014-0458-4] [http://hdl.handle.net/10807/72534]

How to manage aspergillosis in non-neutropenic intensive care unit patients

Antonelli, Massimo
2014

Abstract

Invasive aspergillosis has been mainly reported among immunocompromised patients during prolonged periods of neutropenia. Recently, however, non-neutropenic patients in the ICU population have shown an increasing risk profile for aspergillosis. Associations with chronic obstructive pulmonary disease and corticosteroid therapy have been frequently documented in this cohort. Difficulties in achieving a timely diagnosis of aspergillosis in non-neutropenic patients is related to the non-specificity of symptoms and to lower yields with microbiological tests compared to neutropenic patients. Since high mortality rates are typical of invasive aspergillosis in critically ill patients, a high level of suspicion and prompt initiation of adequate antifungal treatment are mandatory. Epidemiology, risk factors, diagnostic algorithms, and different approaches in antifungal therapy for invasive aspergillosis in non-neutropenic patients are reviewed.
Inglese
Bassetti, M., Righi, E., De Pascale, G., De Gaudio, R., Giarratano, A., Mazzei, T., Morace, G., Petrosillo, N., Stefani, S., Antonelli, M., How to manage aspergillosis in non-neutropenic intensive care unit patients, <<CRITICAL CARE>>, 2014; 18 (4): 458-458. [doi:10.1186/s13054-014-0458-4] [http://hdl.handle.net/10807/72534]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/72534
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 33
social impact